All-in-one, Wireless, Nanomembrane Wearable (GT-Biopatch) device for Continuous Monitoring of Neonates in Ethiopia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202412476096257

Enrollment

100

Registered

2024-12-23

Start date

2023-10-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous monitoring of vital signs

Interventions

experimental group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Neonates both term and preterm (0-7 days of age) admitted to NICU at TASH

Exclusion criteria

Exclusion criteria: Critically sick neonates Recommendation against inclusion from the attending physician. If parents refuse to participate Surgical patient if the attached device is closer to the wound site

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
feasibility and acceptability	—

Countries

Ethiopia

Contacts

Public ContactMichele Joseph

Clinical Trials Coordinator

michelejoseph68@gmail.com0929142593

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026